🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sara F. Dunne

ORCID: 0000-0002-0273-680X
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cells”.

Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.04.075036
N/A
0DataRank · unranked
4 citations

Chi‐Hao Luan, James E. Audia, Sara F. Dunne, Carissa M. Heath, Jonathan Leis

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

Cell chemical biology(2021)10.1016/j.chembiol.2021.08.011
N/A
0DataRank · unranked
22 citations

Michelle Velyunskiy, Sara F. Dunne, Byoung-Kyu Cho, Deepak Kanojia, Lauren R. Begg +15 more

Ilaprazole and Other Novel Prazole-Based Compounds That Bind Tsg101 Inhibit Viral Budding of Herpes Simplex Virus 1 and 2 and Human Immunodeficiency Virus from Cells

Journal of Virology(2021)10.1128/jvi.00190-21
N/A
0DataRank · unranked
20 citations

Chi‐Hao Luan, James E. Audia, Sara F. Dunne, Carissa M. Heath, Jonathan Leis

Genes Involved in Maintaining Mitochondrial Membrane Potential Upon Electron Transport Chain Disruption

Frontiers in Cell and Developmental Biology(2022)10.3389/fcell.2022.781558
N/A
0DataRank · unranked
34 citations

Matt Clutter, Sara F. Dunne, Mariam D. George, Chi‐Hao Luan, Navdeep S. Chandel +2 more

S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.21.558870
N/A
0DataRank · unranked
1 citations

Adrienne Orriols, Μαρκέλλα Ζαννίκου, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia +12 more

S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models

Communications Medicine(2024)10.1038/s43856-024-00444-8
N/A
0DataRank · unranked
8 citations

Adrienne Orriols, Μαρκέλλα Ζαννίκου, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia +12 more

Exploiting the DCAF16–SPIN4 interaction to identify DCAF16 ligands for PROTAC development

RSC Medicinal Chemistry(2024)10.1039/d4md00681j
N/A
0DataRank · unranked
6 citations

Miguel Campos, Xiao‐Kang Jin, Fiona Y. Wang, Chenlu Zhang, Sara F. Dunne +3 more

Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00026
N/A
0DataRank · unranked
24 citations

Prashant V. Bommi, Arabela A. Grigorescu, Kristen L. Lauing, Yingyu Mao, P Berardi +20 more

Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0298
N/A
0DataRank · unranked
0 citations

Atul Jain, Matt Clutter, Dominik A. Nahotko, Emely Lopez Fajardo, Purav P. Vagadia +20 more